The probiotic category continues to grow rapidly on a global basis. And with growth comes increased interest probiotics and microbiome modulation therapies from the pharmaceutical sector. But is this increased interest a good thing for the traditional probiotic players?
from NutraIngredients RSS http://ift.tt/2lVRm5l
via IFTTT